International perspectives on antiretroviral resistance. Introduction.
作者信息
Volberding P, Lange J
机构信息
University of California, San Francisco, Positive Health Program, San Francisco, California, USA.
出版信息
J Acquir Immune Defic Syndr. 2001 Mar 1;26 Suppl 1:S1-2. doi: 10.1097/00042560-200103011-00001.
Abstract
摘要
相似文献
1
International perspectives on antiretroviral resistance. Introduction.
J Acquir Immune Defic Syndr. 2001 Mar 1;26 Suppl 1:S1-2. doi: 10.1097/00042560-200103011-00001.
2
HIV drug resistance testing: an update for the clinician.
AIDS Clin Care. 2001 Oct;13(10):89-91, 94-6, 100.
3
[Incorporation of the test of resistance to antiretroviral drugs in clinical practice].
Med Clin (Barc). 1999 Mar 27;112(11):412-5.
4
Report from the 4th International Workshop on HIV Drug Resistance and Treatment Strategies.
Res Initiat Treat Action. 2000 Sep;6(3):26-9.
5
Revisiting resistance (this isn't getting any easier).
IAPAC Mon. 2000 Aug;6(8):221-38.
6
How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
IAPAC Mon. 2001 Mar;7(3):85-90.
7
HIV genotype and phenotype--arresting resistance?
JAMA. 2000 May 10;283(18):2442-4. doi: 10.1001/jama.283.18.2442.
8
Putting resistance to the test.
Posit Living. 2001 Apr;10(3):15-6, 43-6.
9
HIV drug resistance testing: data be damned.
Res Initiat Treat Action. 2000 Dec;6(4):25-7.
10
[Tests to detect resistance to antiretroviral agents in clinical practice].
Rev Clin Esp. 1999 Mar;199(3):179-83.
引用本文的文献
1
Novel 2-chloro-8-arylthiomethyldipyridodiazepinone derivatives with activity against HIV-1 reverse transcriptase.
Molecules. 2007 Feb 20;12(2):218-30. doi: 10.3390/12020218.
Zotero 插件